Heart dysfunction in patients with acute ischemic stroke or TIA does not predict all-cause mortality at long-term follow-up

Table 2 Characteristics of the acute ischemic stroke or TIA cohort by survival at the end of the follow-up period

	Non-survivors	Survivors	P-values
n = 132	n = 39	n = 93
Age (mean ± SD)	77.5 ± 6.8^**	71.5 ± 9.6	0.001
Stroke (%)	97.4^*	80.6	0.012
TIA (%)	2.6^*	19.4	0.012
mRS at 3-months follow-up
≤2 (%)	69.2^**	91.3	0.001
>2 (%)	30.8^**	8.7	0.001
Laboratory variables
CRP (mg/L)	28.0 ± 48.9^*	11.4 ± 21.2	0.012
Echocardiogram parameters
LVEF	55.0 ± 12.3^*	58.8 ± 8.2	0.043
Cardiovascular risk factors
Smoking (%)	29.6^**	9.1	0.009
Cardiovascular diseases
Myocardial infarction (%)	28.2^*	10.8	0.012
Angina pectoris (%)	25.6^*	11.8	0.048
Comorbidity
eGFR <60 (mL/min) (%)¹	47.2^*	26.1	0.023
Anaemia (%)²	21.1^*	7.8	0.033
Pre-stroke medication
Clopidogrel (%)	5.1^*	0.0	0.028
Post-stroke medication
Aspirin (%)	71.1^*	87.1	0.029

Only variables that are significant are listed in the table.
mRS, Modified rankin scale; CRP, C-reactive protein; LVEF, left ventricular ejection fraction; eGFR, estimated glomerular filtration rate.
¹eGFR estimated by Cockcroft-Gault formula.
²Anaemia according to WHO definition, as hemoglobin <130 g/L (males) and hemoglobin <120 g/L (females).
^*, P < 0.05; ^**, P < 0.01 non-survivors compared with survivors.

ISSN: 1471-2377